Nasdaq · CIK 0001593984
MDWD MediWound Ltd.
Insider trading from SEC Form 4. Last filing 41 d ago. Close $12.54 on Oct 9, 2026, +1% from the 52-week low and -36% from the high.
MediWound Ltd. (MDWD) has 2 SEC Form 4 filings on file from 2 insiders, the latest filed on Sep 2, 2026. In the last 90 days insiders made 1 open-market buy worth $6,626 and 1 open-market sell worth $6,678, net -$53.
3 open-market trades have been scored at MDWD. The newest: Samuel Rubinstein (director) bought $6,626 of stock on Sep 1, 2026, filed Sep 2, 2026, scored 23 (weak). The largest of the 3 shown: David Morton Fox (director) bought $50k on Jun 1, 2026, scored 43 (moderate).
MDWD closed at $12.54 on Oct 9, 2026, 1% above its 52-week low and 36% below its 52-week high.
1 Form 144 notice of planned sales is on file, the latest filed Dec 3, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at MediWound Ltd., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Samuel Rubinstein director buy | $6,626 525 shares | - | - | |
| 35Weak | Samuel Rubinstein director sell | $6,678 525 shares | -100% | - | |
| 43Moderate | David Morton Fox director buy | $50k 3,537 shares | +19% | 0% from low-38% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 3, 2025 | Hess Shmuel Officer | 3,693 0.03% of outstanding | $64k | Dec 2, 2025 | none |
Transactions
Every row filed, 5 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Samuel Rubinstein director | SOpen-market sale Ordinary Sharesindirect: By spouse | -525 | $12.72 | $6,678 | 0 | 41 d ago |
| Sep 1, 2026 | Samuel Rubinstein director | POpen-market purchase Ordinary Sharesindirect: By spouse | +525 | $12.62 | $6,626 | 525 | 41 d ago |
| Jun 1, 2026 | David Morton Fox director | POpen-market purchase Ordinary Shares | +1,730 | $14.23 | $25k | 20,476 | Jun 2, 2026 |
| Jun 1, 2026 | David Morton Fox director | POpen-market purchase Ordinary Shares | +10 | $14.23 | $142 | 20,486 | Jun 2, 2026 |
| Jun 1, 2026 | David Morton Fox director | POpen-market purchase Ordinary Shares | +1,797 | $14.00 | $25k | 22,283 | Jun 2, 2026 |
Questions about MDWD
Answered from the filings on this page, as of the latest one.
Are insiders buying MDWD?
As of Sep 2, 2026, SEC Form 4 filings show 1 open-market buy worth $6,626 by 1 insider and 1 open-market sell worth $6,678 by 1 insider at MediWound Ltd. in the last 90 days, net -$53. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade MDWD on the open market?
Samuel Rubinstein (director) bought $6,626 of MDWD on Sep 1, 2026 and filed the Form 4 on Sep 2, 2026. InsiderTell scored 23 (weak).
How many insiders file Form 4 at MediWound Ltd.?
2 people have filed a Form 4 at MediWound Ltd., among them David Morton Fox (director), Samuel Rubinstein (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.